Armistice Capital’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8M | Sell |
6,200,000
-372,000
| -6% | -$2.15M | 0.62% | 22 |
|
|
2025
Q1 | $43.4M | Buy |
6,572,000
+772,000
| +13% | +$5.1M | 0.65% | 28 |
|
|
2024
Q4 | $50.5M | Buy |
5,800,000
+3,142,000
| +118% | +$27.4M | 0.69% | 27 |
|
|
2024
Q3 | $51.9M | Buy |
2,658,000
+308,000
| +13% | +$6.02M | 0.83% | 20 |
|
|
2024
Q2 | $48.4M | Buy |
2,350,000
+302,000
| +15% | +$6.22M | 0.61% | 27 |
|
|
2024
Q1 | $43.7M | Sell |
2,048,000
-176,000
| -8% | -$3.75M | 0.58% | 25 |
|
|
2023
Q4 | $32M | Sell |
2,224,000
-12,000
| -0.5% | -$173K | 0.44% | 38 |
|
|
2023
Q3 | $20.4M | Buy |
2,236,000
+112,000
| +5% | +$1.02M | 0.31% | 52 |
|
|
2023
Q2 | $22.5M | Buy |
2,124,000
+888,000
| +72% | +$9.4M | 0.33% | 54 |
|
|
2023
Q1 | $15.1M | Buy |
1,236,000
+164,000
| +15% | +$2.01M | 0.22% | 74 |
|
|
2022
Q4 | $13.3M | Buy |
+1,072,000
| New | +$13.3M | 0.23% | 64 |
|